EMAIL US: customerservice@franklinyoung.com
CALL US: (618) 724-2780 / (909) 931-5012
CALL US: (618) 724-2780 / (909) 931-5012
Back to Previous Page
ITEM#: 3042-Y0001978
MFR#: Y0001978
Y0001978 Biotin for system suitability European Pharmacopoe
| Product Name | Description | Item# | QTY | |
|---|---|---|---|---|
Mycophenolate for system suitability European Pharmacopoeia (EP) Reference Standard
|
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuin | 3042-Y0002200 | EA | |
Ticagrelor for system suitability European Pharmacopoeia (EP) Reference Standard
|
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuin | 3042-Y0002223 | EA | |
Riociguat for FP system suitability CRS, European Pharmacopoeia (EP) Reference Standard
|
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuin | 3042-Y0002240 | EA | |
Regorafenib for FP system suitability CRS, European Pharmacopoeia (EP) Reference Standard
|
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuin | 3042-Y0002225 | EA | |
Riociguat for system suitability CRS, European Pharmacopoeia (EP) Reference Standard
|
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuin | 3042-Y0002239 | EA |